Delivery Order SPE2DB20D2014-SPE2DB24FB25K
- Not listed
- This federal contract award is for the delivery of Trelegy Ellipta 100-62.5-25 60S pharmaceutical products to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, which is a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $8,049.34 and an ultimate completion date of June 26, 2023. The contract is a Firm Fixed Price Delivery Order and was awarded on June 23, 2023. There is no set-aside...
- This federal contract award from the Defense Logistics Agency (DLA) is a delivery order valued at $45,737.71 for Trelegy Ellipta 100-62.5-25 60s, a pharmaceutical product, to the prime contractor Amerisourcebergen Drug Corp. The contract has an ultimate completion date of January 28, 2025 and is a firm fixed price contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare...
- This federal contract award is for the delivery of the pharmaceutical product Trelegy Ellipta 100-62.5-25 60S, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $2,008.68 and is a firm fixed-price delivery order with an ultimate completion date of August 4, 2021. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of Trelegy Ellipta, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $9,891.00 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of January 17, 2024 and was awarded on January 16, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $5,016.40, is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product. The award has a performance period through February 12, 2024 and is a Firm Fixed Price Delivery Order contract. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
- This federal contract award is for the delivery of pharmaceutical products, specifically the drug Trelegy Ellipta, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,346.04 and is a firm fixed-price delivery order, with a completion date of January 26, 2024. The contract was awarded on January 25, 2024, and there is no set-aside designation....
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Trelegy Ellipta 100-62.5-25 60S medication. The contract, valued at $25,100.02, was awarded by the Defense Logistics Agency (DLA) on February 7, 2023, with a completion date of February 8, 2023. This is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Trelegy Ellipta pharmaceutical products, valued at $2,680.83. The award was made by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. This is a delivery order contract with a firm-fixed price pricing type. The contract has a completion date of June 18, 2024 and was...
- This federal contract award is for the delivery of the pharmaceutical product Trelegy Ellipta 100-62.5-25 60s to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $21,449.54, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order with a firm fixed price, and the ultimate completion date is December 8, 2023. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is a major...
- This federal contract award is for the delivery of Trelegy Ellipta 200-62.5-25 60s, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $9,551.73 and is a delivery order with a firm fixed price pricing type. The award has no set-aside designation, indicating it was...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FB25KDelivery Order
This federal contract award is for the delivery of Trelegy Ellipta 100-62.5-25 prescription medications to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $11,216.89 and an ultimate completion date of March 7, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. The award was made on March 6, 2024, and there is no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.2k | 3/6/24 |